[1] |
许巧玲, 应江山, 崔冉, 等. miR-30b促进弥漫性大B细胞淋巴瘤细胞凋亡[J]. 基础医学与临床, 2022, 42: 268-273.
|
[2] |
Sukswai N, Lyapichev K, Khoury JD, et al. Diffuse large B-cell lymphoma variants: an update[J]. Pathology, 2020, 52: 53-67.
|
[3] |
Miyazaki K. Treatment of diffuse large B-cell lymphoma[J]. J Clin Exp Hematop, 2016, 56: 79-88.
|
[4] |
Pasqualucci L, Dalla-Favera R. Genetics of diffuse large B-cell lymphoma[J]. Blood, 2018, 131: 2307-2319.
|
[5] |
Ganapathy AS, Saha K, Suchanec E, et al. AP2M1 mediates autophagy-induced CLDN2 (claudin 2) degradation through endocytosis and interaction with LC3 and reduces intestinal epithelial tight junction permeability[J]. Autophagy, 2022, 18: 2086-2103.
|
[6] |
周颖, 何松. 基于生物信息学探索弥漫大B细胞淋巴瘤的分子机制[J]. 中国实验血液学杂志, 2020, 28: 1585-1591.
|
[7] |
Song X, Li M, Wu W, et al. Regulation of BMP2K in AP2M1-mediated EGFR internalization during the development of gallbladder cancer[J]. Signal Transduct Target Ther, 2020, 5: 154. doi: 10.1038/s41392-020-00250-3.
|
[8] |
Tebbutt N, Pedersen MW, Johns TG. Targeting the ERBB family in cancer: couples therapy[J]. Nat Rev Cancer, 2013, 13: 663-673.
|
[9] |
Erira A, Velandia F, Penagos J, et al. Differential regulation of the EGFR/PI3K/AKT/PTEN pathway between low- and high-grade gliomas[J]. Brain Sci, 2021, 11: 1655. doi: 10.3390/brainsci11121655.
|
[10] |
Cho SH, Pak K, Jeong DC, et al. The AP2M1 gene expression is a promising biomarker for predicting survival of patients with hepatocellular carcinoma[J]. J Cell Biochem, 2019, 120: 4140-4146.
|
[11] |
Neveu G, Ziv-Av A, Barouch-Bentov R, et al. AP-2-associated protein kinase 1 and cyclin G-associated kinase regulate hepatitis C virus entry and are potential drug targets[J]. J Virol, 2015, 89: 4387-4404.
|
[12] |
Rappoport JZ, Simon SM. Endocytic trafficking of activated EGFR is AP-2 dependent and occurs through preformed clathrin spots[J]. J Cell Sci, 2009, 122: 1301-1305.
|
[13] |
Wiley HS. Trafficking of the ErbB receptors and its influence on signaling[J]. Exp Cell Res, 2003, 284: 78-88.
|
[14] |
Tomas A, Futter CE, Eden ER. EGF receptor trafficking: consequences for signaling and cancer[J]. Trends Cell Biol, 2014, 24: 26-34.
|